title: Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab.
authors.affiliation: Alberta Blood and Marrow Transplant Program and University of Calgary, Calgary, Alberta, Canada. Electronic address: jstorek@ucalgary.ca.
authors.forename: Jan
authors.initials: J
authors.lastname: Storek
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D020127:Recovery of Function; D019172:Transplantation Conditioning
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents